Literature DB >> 19764025

Tethered cord, corpus callosum abnormalities, and periventricular cysts in Wolf-Hirschhorn syndrome. Report of two cases and review of the literature.

Joel Verbrugge1, Arabinda Kumar Choudhary, Roger Ladda.   

Abstract

Wolf-Hirschhorn syndrome (4p-) is a rare disorder with characteristic physical findings. Neuroimaging findings are relatively scarce. We performed a literature search and found 22 reports of neuroimaging findings. We present findings in our two cases, each with the previously unreported finding of a tethered cord. The most common abnormalities were of the corpus callosum, occurring in 71% of all cases. There appears to be a high association in the syndrome between corpus callosal abnormalities and periventricular cysts formation in the first year of life. These cysts eventually fuse with the frontal horns during late infancy with enlargement of the frontal horns. Absence of other causes for periventricular cyst formation, such as perinatal distress, prematurity, or cytomegalovirus infection, appears to strengthen the association. With further studies, neuroimaging findings may eventually assist in the diagnosis of patients with Wolf-Hirschhorn syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19764025     DOI: 10.1002/ajmg.a.33022

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Auditory hair cell defects as potential cause for sensorineural deafness in Wolf-Hirschhorn syndrome.

Authors:  Mohi Ahmed; Kiyoe Ura; Andrea Streit
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

2.  A large Indian family with rearrangement of chromosome 4p16 and 3p26.3 and divergent clinical presentations.

Authors:  Thomas Iype; Vafa Alakbarzade; Mary Iype; Royana Singh; Ajith Sreekantan-Nair; Barry A Chioza; Tribhuvan M Mohapatra; Emma L Baple; Michael A Patton; Thomas T Warner; Christos Proukakis; Abhi Kulkarni; Andrew H Crosby
Journal:  BMC Med Genet       Date:  2015-11-10       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.